Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation
US-9073957-B2 · Jul 7, 2015 · US
US10098901B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10098901-B2 |
| Application number | US-201515310455-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 13, 2015 |
| Priority date | May 14, 2014 |
| Publication date | Oct 16, 2018 |
| Grant date | Oct 16, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to novel derivatives of oxazaphosphorines, pharmaceutical compositions and therapeutic uses thereof, in particular for treating or preventing cancer.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula (I): wherein: A is selected from the group consisting of: O, S, —O—(C═S)—S—, —ONH—, —ONR′—, —NR′O—, —NHO—, Y 1 —(CH 2 ) n —Y 2 , where n is an integer from 1 to 8, and Y 1 —(CH 2 —CH 2 —O) a —CH 2 —CH 2 —Y 2 where a is an integer from 1 to 5, wherein Y 1 and Y 2 are independently selected from —O—, —NH—, —S—, —OC(O)—, —C(O)NH—, —NHC(O)—, —O—C(S)—S—, S—C(S)—O—NR′—, —ONH—, —NHO—, —ONR′—, —NR′O—, —OC(O)—O—, NR′C(S)S—, —SC(S)NR′—, —NR′C(O)—, —C(O)NR′— and —C(O)O—, and R′ is a C 1 -C 6 alkyl, and wherein —R 1 , R 2 and R 3 are independently selected from the group consisting of —H, —CH(CH 3 )—CH 2 —X and —(CH 2 ) 2 —X, X being a halogen atom, or a pharmaceutically acceptable salt or solvate thereof. 2. A compound selected from the group consisting of: and pharmaceutically acceptable salts thereof. 3. A pharmaceutical composition comprising a compound as an active ingredient and a pharmaceutically acceptable excipient, wherein the compound is:
Antineoplastic agents · CPC title
the modifying agent being an organic compound · CPC title
Amides of phosphorus acids · CPC title
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids (hydroxamic acids A61K31/16; peroxy acids A61K31/327) · CPC title
the phosphorus atom being part of a six-membered ring which may be condensed with another ring system · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.